Your Best Stock
$148.29
+$0.31 (+0.21%)
Market open · Sep 25, 3:00 pm ET
After hours $148.19 +0.14%
Open$148.29
Prev close$147.98
Day range$147.48 – $149.94
Volume4.23M
Market cap$365.86B
P/E (TTM)118.6
Dividend yield2.27%

Earnings

Average move on report day±2.8%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+4.6%
Worst reaction-9.8%

Stock move on the day after each report

+1.9%2023/Q3+4.6%2023/Q4+2.9%2024/Q1-9.8%2024/Q2-2.4%2024/Q3-9.1%2024/Q4+1.4%2025/Q1-1.7%2025/Q2-0.3%2025/Q3+2.2%2025/Q4-1.6%2026/Q1+0.2%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026Pre Market±5.7%+0.18%Within range
2026/Q130 Apr 2026Pre Market±4.6%-1.60%Within range
2025/Q43 Feb 2026Pre Market±5.2%+2.18%Within range
2025/Q330 Oct 2025Pre Market±3.4%-0.35%Within range
2025/Q229 Jul 2025Pre Market±4.2%-1.70%Within range
2025/Q124 Apr 2025Pre Market±4.5%+1.40%Within range
2024/Q44 Feb 2025Pre Market±5.1%-9.07%Bigger than priced
2024/Q331 Oct 2024Pre Market±5.1%-2.39%Within range
2024/Q230 Jul 2024Pre Market±5.4%-9.81%Bigger than priced
2024/Q125 Apr 2024Pre Market±4.0%+2.93%Within range
2023/Q41 Feb 2024Pre Market±3.1%+4.64%Bigger than priced
2023/Q326 Oct 2023Pre Market±2.9%+1.85%Within range
2023/Q21 Aug 2023Pre Market±3.7%-1.28%Within range
2023/Q127 Apr 2023–±3.5%+1.53%Within range
2022/Q42 Feb 2023Pre Market±3.3%-3.29%Within range
2022/Q327 Oct 2022Pre Market±3.1%+1.35%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Pharmaceutical$14.76B 88.9%
  • Animal health$1.78B 10.7%
  • Other$72.00M 0.4%

Latest reported quarter: Q2, ended Jun 2026

Revenue$16.61B+5.1% YoY
Operating profit-$433.00M-107.8% YoY
Net profit-$1.34B-130.2% YoY
Diluted EPS-$0.54-130.7% YoY
Free cash flow$4.48B+77.0% YoY
Operating cash flow$5.37B

Revenue, last 8 quarters

$16.7BSep '24$15.6BDec '24$15.5BMar '25$15.8BJun '25$17.3BSep '25$16.4BDec '25$16.3BMar '26$16.6BJun '26

Net profit, last 8 quarters

$3.2BSep '24$3.7BDec '24$5.1BMar '25$4.4BJun '25$5.8BSep '25$3.0BDec '25$-4.2BMar '26$-1.3BJun '26

Profitability & balance sheet

Gross margin73.0%
Operating margin10.5%
Net margin4.8%
Return on equity7.0%
Return on assets2.6%
Return on invested capital4.5%
Current ratio1.32
Liabilities / assets67.7%
Cash & investments$7.14B
Total debt$53.91B
Net cash (debt)-$46.77B
Free cash flow / sales24.1%
Scroll to Top